T2 Biosystems Stock Retained Earnings
| TTOODelisted Stock | USD 0.18 0.05 21.74% |
T2 Biosystems fundamentals help investors to digest information that contributes to T2 Biosystems' financial success or failures. It also enables traders to predict the movement of TTOO Pink Sheet. The fundamental analysis module provides a way to measure T2 Biosystems' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to T2 Biosystems pink sheet.
TTOO |
T2 Biosystems Company Retained Earnings Analysis
T2 Biosystems' Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current T2 Biosystems Retained Earnings | (584.3 M) |
Most of T2 Biosystems' fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, T2 Biosystems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
CompetitionBased on the latest financial disclosure, T2 Biosystems has a Retained Earnings of (584.3 Million). This is 162.74% lower than that of the Biotechnology sector and 189.88% lower than that of the Health Care industry. The retained earnings for all United States stocks is 106.26% higher than that of the company.
TTOO Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses T2 Biosystems' direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of T2 Biosystems could also be used in its relative valuation, which is a method of valuing T2 Biosystems by comparing valuation metrics of similar companies.T2 Biosystems is currently under evaluation in retained earnings category among its peers.
TTOO Fundamentals
| Return On Equity | -6.22 | ||||
| Return On Asset | -0.9 | ||||
| Operating Margin | (4.91) % | ||||
| Current Valuation | 21.91 M | ||||
| Shares Outstanding | 21.04 M | ||||
| Shares Owned By Insiders | 10.17 % | ||||
| Shares Owned By Institutions | 73.51 % | ||||
| Number Of Shares Shorted | 826.91 K | ||||
| Price To Earning | (2.04) X | ||||
| Price To Book | 14.50 X | ||||
| Price To Sales | 0.69 X | ||||
| Revenue | 7.19 M | ||||
| Gross Profit | (24.77 M) | ||||
| EBITDA | (43.88 M) | ||||
| Net Income | (50.08 M) | ||||
| Cash And Equivalents | 13.21 M | ||||
| Cash Per Share | 1.87 X | ||||
| Total Debt | 49.5 M | ||||
| Debt To Equity | 6.64 % | ||||
| Current Ratio | 1.87 X | ||||
| Book Value Per Share | (6.91) X | ||||
| Cash Flow From Operations | (48.14 M) | ||||
| Short Ratio | 1.26 X | ||||
| Earnings Per Share | (0.03) X | ||||
| Target Price | 5.0 | ||||
| Number Of Employees | 113 | ||||
| Beta | 0.38 | ||||
| Market Capitalization | 10.48 M | ||||
| Total Asset | 34.8 M | ||||
| Retained Earnings | (584.3 M) | ||||
| Working Capital | (30.96 M) | ||||
| Current Asset | 77.78 M | ||||
| Current Liabilities | 18.54 M | ||||
| Net Asset | 34.8 M |
About T2 Biosystems Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze T2 Biosystems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of T2 Biosystems using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of T2 Biosystems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in TTOO Pink Sheet
If you are still planning to invest in T2 Biosystems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the T2 Biosystems' history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |